Close Menu

New guidelines are being introduced in the US for companies that supply "custom DNA," in order to guard against bioterrorists looking to build dangerous viruses from the genes up, says the New Scientist. Several firms supply DNA sequences to order, and as the New Scientist reported in 2005, only five out of the 12 that do so in North America and Europe screened every order for sequences that could be used in bioweapons.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.